NANOPORE BIOSENSOR FOR QUANTIFICATION OF THE ISOMERS OF PLATELET-DERIVED GROWTH FACTOR PROTEIN
2015
- 15Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage15
- Downloads11
- Abstract Views4
Artifact Description
Our project’s goal is to use nanopore analysis to detect cancers from the expression of protein for early screenings of cancer. Preliminary work uses a nanopore chip to detect specific proteins. Our research targeted the platelet-derived growth factor (PDGF) protein that is an important biomarker for certain cancers like leukemia and lymphoma. Discrimination between two isomers of the PDGF protein, PDGF AA and PDGF AB, was the target of experiments through the nanopore. For selectivity, an aptamer, a molecule made up of specific RNA nucleotides, was introduced in the solution. The aptamer had a very high affinity for PDGF AB, whereas it had almost no affinity for PDGF AA. Because aptamer attachment added more charge to the overall, it would result in different translocation profiles for the two isomers. These profiles will be used in rigorous analysis to quantify the two isomers of the protein, in the hopes of providing higher-level screenings of certain cancers.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know